NASDAQ:OXFD - Oxford Immunotec Global Stock Price, Forecast & News

Oxford Immunotec Global trades on the NASDAQ under the ticker symbol "OXFD."

Oxford Immunotec Global PLC (NASDAQ:OXFD) announced its earnings results on Tuesday, November, 5th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.05) by $0.09. The firm had revenue of $21.20 million for the quarter, compared to analyst estimates of $20.23 million. Oxford Immunotec Global had a net margin of 199.21% and a return on equity of 15.77%. The business's revenue was up 31.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.13) EPS. View Oxford Immunotec Global's Earnings History.

Oxford Immunotec Global is scheduled to release their next quarterly earnings announcement on Monday, March 9th 2020. View Earnings Estimates for Oxford Immunotec Global.

2 Wall Street analysts have issued 1-year price targets for Oxford Immunotec Global's shares. Their forecasts range from $20.00 to $20.00. On average, they anticipate Oxford Immunotec Global's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 23.8% from the stock's current price. View Analyst Price Targets for Oxford Immunotec Global.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Immunotec Global in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Oxford Immunotec Global.

Headlines about OXFD stock have trended positive this week, InfoTrie reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Oxford Immunotec Global earned a news impact score of 3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Oxford Immunotec Global.

Oxford Immunotec Global saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 411,000 shares, a decline of 9.6% from the December 15th total of 454,700 shares. Based on an average trading volume of 122,200 shares, the days-to-cover ratio is currently 3.4 days. Currently, 1.6% of the shares of the company are short sold. View Oxford Immunotec Global's Current Options Chain.

Some companies that are related to Oxford Immunotec Global include Heska (HSKA), Intellia Therapeutics (NTLA), Lantheus (LNTH), Quotient (QTNT), Meridian Bioscience (VIVO), Nymox Pharmaceutical (NYMX), Vermillion (VRML), Celldex Therapeutics (CLDX), ImmuCell (ICCC), Riot Blockchain (RIOT), Trinity Biotech (TRIB), Arca Biopharma (ABIO), GeneNews (GNWSF), Achieve Life Sciences (ACHV) and Akers Biosciences (AKER).

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford Immunotec Global investors own include Immunomedics (IMMU), Halozyme Therapeutics (HALO), Intel (INTC), Sangamo Therapeutics (SGMO), AbbVie (ABBV), Gold Resource (GORO), Adaptimmune Therapeutics (ADAP), Akorn (AKRX), Aptose Biosciences (APTO) and Fate Therapeutics (FATE).

Shares of OXFD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OXFD stock can currently be purchased for approximately $16.15.

Oxford Immunotec Global has a market capitalization of $427.17 million and generates $59.75 million in revenue each year. The company earns $120.78 million in net income (profit) each year or $0.51 on an earnings per share basis. Oxford Immunotec Global employs 215 workers across the globe.View Additional Information About Oxford Immunotec Global.

The official website for Oxford Immunotec Global is http://www.oxfordimmunotec.com/.

Oxford Immunotec Global's mailing address is 94C INNOVATION DRIVE MILTON PARK, ABINGDON X0, OX14 4RZ. The company can be reached via phone at 44-0-12-3544-2780 or via email at [email protected]